Recently, FGF-23, a novel regulator of mineral metabolism which is markedly elevated in AKI [114], is regarded as an index of subclinical cardiovascular pathology and associated with adverse cardiovascular outcome [115]. The gene discussed is FGF23; the disease is acute kidney injury.